FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076342777> ?p ?o ?g. }

• W2076342777 endingPage "89" @default.
• W2076342777 startingPage "89" @default.
• W2076342777 abstract "Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors Ursa Brown-Glaberman, Alison T StopeckUniversity of Arizona Cancer Center, Tucson, AZ, USAAbstract: Skeletal-related events (SREs) including pain, fractures, and hypercalcemia are a major source of morbidity for cancer patients with bone metastases. The receptor activator of NF-κB ligand (RANKL) is a key mediator of osteoclast formation and activity in normal bone physiology as well as cancer-induced bone resorption. The first commercially available drug that specifically targets and inhibits the RANKL pathway is denosumab, a fully human monoclonal antibody that binds and neutralizes RANKL, thereby inhibiting osteoclast function. In this review, we summarize the major studies leading to the US Food and Drug Administration-approval of denosumab for the prevention of SREs in patients with bone metastases from solid tumors. Further, we discuss the role of denosumab in the prevention and treatment of SREs and bone loss in cancer patients. As a monoclonal antibody, denosumab has several advantages over bisphosphonates, including improved efficacy, better tolerability, and the convenience of administration by subcutaneous injection. In addition, as denosumab has no known renal toxicity, it may be the preferred choice over bisphosphonates in patients with baseline renal insufficiency or receiving nephrotoxic therapies. However, other toxicities, including osteonecrosis of the jaw and hypocalcemia, appear to be class effects of agents that potently inhibit osteoclast activity and are associated with both denosumab and bisphosphonate use. The data presented highlight the differences associated with intravenous bisphosphonate and denosumab use as well as confirm the essential role bone-modifying agents play in maintaining the quality of life for patients with bone metastases.Keywords: denosumab, bone metastases, solid tumor, breast cancer, prostate cancer, skeletal related events, skeletal complications" @default.
• W2076342777 created "2016-06-24" @default.
• W2076342777 creator A5009941371 @default.
• W2076342777 creator A5043850374 @default.
• W2076342777 date "2012-04-01" @default.
• W2076342777 modified "2023-10-01" @default.
• W2076342777 title "Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors" @default.
• W2076342777 cites W1534645474 @default.
• W2076342777 cites W1967875617 @default.
• W2076342777 cites W1979118352 @default.
• W2076342777 cites W1982915376 @default.
• W2076342777 cites W1991668450 @default.
• W2076342777 cites W1992053982 @default.
• W2076342777 cites W1996589664 @default.
• W2076342777 cites W2000144084 @default.
• W2076342777 cites W2030339269 @default.
• W2076342777 cites W2039144093 @default.
• W2076342777 cites W2048346627 @default.
• W2076342777 cites W2048964656 @default.
• W2076342777 cites W2049124722 @default.
• W2076342777 cites W2050230292 @default.
• W2076342777 cites W2051255001 @default.
• W2076342777 cites W2054351138 @default.
• W2076342777 cites W2060183015 @default.
• W2076342777 cites W2074719510 @default.
• W2076342777 cites W2088793117 @default.
• W2076342777 cites W2102969047 @default.
• W2076342777 cites W2103904089 @default.
• W2076342777 cites W2107118598 @default.
• W2076342777 cites W2110707581 @default.
• W2076342777 cites W2115871403 @default.
• W2076342777 cites W2115962082 @default.
• W2076342777 cites W2118914286 @default.
• W2076342777 cites W2136646477 @default.
• W2076342777 cites W2139860898 @default.
• W2076342777 cites W2142234592 @default.
• W2076342777 cites W2148096512 @default.
• W2076342777 cites W2149775776 @default.
• W2076342777 cites W2157193896 @default.
• W2076342777 cites W2160005424 @default.
• W2076342777 cites W2165011173 @default.
• W2076342777 cites W2170309090 @default.
• W2076342777 cites W2171595133 @default.
• W2076342777 cites W2227191881 @default.
• W2076342777 cites W2332722304 @default.
• W2076342777 cites W2342404464 @default.
• W2076342777 cites W2418695420 @default.
• W2076342777 cites W2562181424 @default.
• W2076342777 cites W2607028219 @default.
• W2076342777 doi "https://doi.org/10.2147/btt.s20677" @default.
• W2076342777 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3333824" @default.
• W2076342777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22532777" @default.
• W2076342777 hasPublicationYear "2012" @default.
• W2076342777 type Work @default.
• W2076342777 sameAs 2076342777 @default.
• W2076342777 citedByCount "14" @default.
• W2076342777 countsByYear W20763427772012 @default.
• W2076342777 countsByYear W20763427772013 @default.
• W2076342777 countsByYear W20763427772014 @default.
• W2076342777 countsByYear W20763427772015 @default.
• W2076342777 countsByYear W20763427772016 @default.
• W2076342777 countsByYear W20763427772017 @default.
• W2076342777 countsByYear W20763427772018 @default.
• W2076342777 countsByYear W20763427772019 @default.
• W2076342777 countsByYear W20763427772020 @default.
• W2076342777 countsByYear W20763427772021 @default.
• W2076342777 countsByYear W20763427772022 @default.
• W2076342777 crossrefType "journal-article" @default.
• W2076342777 hasAuthorship W2076342777A5009941371 @default.
• W2076342777 hasAuthorship W2076342777A5043850374 @default.
• W2076342777 hasBestOaLocation W20763427771 @default.
• W2076342777 hasConcept C121608353 @default.
• W2076342777 hasConcept C126322002 @default.
• W2076342777 hasConcept C143998085 @default.
• W2076342777 hasConcept C170033053 @default.
• W2076342777 hasConcept C170493617 @default.
• W2076342777 hasConcept C2776033226 @default.
• W2076342777 hasConcept C2776286101 @default.
• W2076342777 hasConcept C2776326535 @default.
• W2076342777 hasConcept C2776541429 @default.
• W2076342777 hasConcept C2777251235 @default.
• W2076342777 hasConcept C2777556957 @default.
• W2076342777 hasConcept C2777783956 @default.
• W2076342777 hasConcept C2779013556 @default.
• W2076342777 hasConcept C2779428903 @default.
• W2076342777 hasConcept C502942594 @default.
• W2076342777 hasConcept C673006 @default.
• W2076342777 hasConcept C71924100 @default.
• W2076342777 hasConcept C88045685 @default.
• W2076342777 hasConceptScore W2076342777C121608353 @default.
• W2076342777 hasConceptScore W2076342777C126322002 @default.
• W2076342777 hasConceptScore W2076342777C143998085 @default.
• W2076342777 hasConceptScore W2076342777C170033053 @default.
• W2076342777 hasConceptScore W2076342777C170493617 @default.
• W2076342777 hasConceptScore W2076342777C2776033226 @default.
• W2076342777 hasConceptScore W2076342777C2776286101 @default.
• W2076342777 hasConceptScore W2076342777C2776326535 @default.
• W2076342777 hasConceptScore W2076342777C2776541429 @default.

• next